一名多发性骨髓瘤胸膜定位患者对硼替佐米有显著反应。 - Suppr

Suppr

超能文献

A striking response to bortezomib in a patient with pleural localization of multiple myeloma.

作者信息

Mangiacavalli Silvia, Varettoni Marzia, Zappasodi Patrizia, Pica Gianmatteo, Lazzarino Mario, Corso Alessandro

出版信息

Leuk Res. 2009 Apr;33(4):577-8. doi: 10.1016/j.leukres.2008.08.027. Epub 2008 Oct 7.

DOI:10.1016/j.leukres.2008.08.027

PMID:18842298

Abstract

摘要

相似文献

A striking response to bortezomib in a patient with pleural localization of multiple myeloma.

Leuk Res. 2009 Apr;33(4):577-8. doi: 10.1016/j.leukres.2008.08.027. Epub 2008 Oct 7.

Use of intrapleural bortezomib in myelomatous pleural effusion.

Br J Haematol. 2007 Nov;139(4):621-2. doi: 10.1111/j.1365-2141.2007.06735.x.

Bortezomib therapy following first relapse.

Oncology (Williston Park). 2005 Jan;19(1):23-6.

Hemostatic effects of bortezomib treatment in patients with relapsed or refractory multiple myeloma.

Haematologica. 2008 Jun;93(6):953-4. doi: 10.3324/haematol.12522.

Concurrent radiation therapy and bortezomib in myeloma patient.

Radiother Oncol. 2008 Feb;86(2):290-2. doi: 10.1016/j.radonc.2007.12.015. Epub 2008 Jan 15.

Effects of bortezomib on bone disease in multiple myeloma.

Am J Hematol. 2009 Jan;84(1):1-2. doi: 10.1002/ajh.21324.

Efficacy of bortezomib in systemic extramedullary localizations of multiple myeloma.

Clin Adv Hematol Oncol. 2012 Apr;10(4):266-8.

Severe pulmonary complications after bortezomib treatment for multiple myeloma: an unrecognized pulmonary vasculitis?

Leuk Res. 2007 Jul;31(7):1027-8. doi: 10.1016/j.leukres.2006.09.015. Epub 2006 Nov 28.

[Bortezomib in second-line therapy].

Med Monatsschr Pharm. 2005 Sep;28(9):332-3.

Inefficacy of bortezomib therapy for CNS involvement of refractory multiple myeloma.

Leuk Res. 2007 May;31(5):721-3. doi: 10.1016/j.leukres.2006.06.019. Epub 2006 Aug 4.

引用本文的文献

Bilateral myelomatous pleural effusion: presentation of two cases.

Blood Res. 2016 Jun;51(2):142-4. doi: 10.5045/br.2016.51.2.142. Epub 2016 Jun 23.

Myelomatous Pleural Effusion: Case report and review of the literature.

Sultan Qaboos Univ Med J. 2011 May;11(2):259-64. Epub 2011 May 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

A striking response to bortezomib in a patient with pleural localization of multiple myeloma.

Leuk Res. 2009 Apr;33(4):577-8. doi: 10.1016/j.leukres.2008.08.027. Epub 2008 Oct 7.

Use of intrapleural bortezomib in myelomatous pleural effusion.

Br J Haematol. 2007 Nov;139(4):621-2. doi: 10.1111/j.1365-2141.2007.06735.x.

Bortezomib therapy following first relapse.

Oncology (Williston Park). 2005 Jan;19(1):23-6.

Hemostatic effects of bortezomib treatment in patients with relapsed or refractory multiple myeloma.

Haematologica. 2008 Jun;93(6):953-4. doi: 10.3324/haematol.12522.

Concurrent radiation therapy and bortezomib in myeloma patient.

Radiother Oncol. 2008 Feb;86(2):290-2. doi: 10.1016/j.radonc.2007.12.015. Epub 2008 Jan 15.

Effects of bortezomib on bone disease in multiple myeloma.

Am J Hematol. 2009 Jan;84(1):1-2. doi: 10.1002/ajh.21324.

Efficacy of bortezomib in systemic extramedullary localizations of multiple myeloma.

Clin Adv Hematol Oncol. 2012 Apr;10(4):266-8.

Severe pulmonary complications after bortezomib treatment for multiple myeloma: an unrecognized pulmonary vasculitis?

Leuk Res. 2007 Jul;31(7):1027-8. doi: 10.1016/j.leukres.2006.09.015. Epub 2006 Nov 28.

[Bortezomib in second-line therapy].

Med Monatsschr Pharm. 2005 Sep;28(9):332-3.

Inefficacy of bortezomib therapy for CNS involvement of refractory multiple myeloma.

Leuk Res. 2007 May;31(5):721-3. doi: 10.1016/j.leukres.2006.06.019. Epub 2006 Aug 4.

引用本文的文献

Bilateral myelomatous pleural effusion: presentation of two cases.

Blood Res. 2016 Jun;51(2):142-4. doi: 10.5045/br.2016.51.2.142. Epub 2016 Jun 23.

Myelomatous Pleural Effusion: Case report and review of the literature.

Sultan Qaboos Univ Med J. 2011 May;11(2):259-64. Epub 2011 May 15.